5 hours GSK Q3 Earnings Top, Stock Down on Lowered ’24 View for Vaccine SalesZacks
GSK’s Q3 earnings beat estimates but sales miss the same. The company also lowers its outlook for vaccine sales for the rest of the year due to weak U.S. demand.
XGSK’s Q3 earnings beat estimates but sales miss the same. The company also lowers its outlook for vaccine sales for the rest of the year due to weak U.S. demand.
X